Ibnsina Pharma
Ibnsina Pharma operates in various business sectors.
Market Cap & Net Worth: Ibnsina Pharma (ISPH)
Ibnsina Pharma (EGX:ISPH) has a market capitalization of $2.04K (EGP102.93K) as of March 19, 2026. Listed on the EGX stock exchange, this Egypt-based company holds position #47381 globally and #129 in its home market, demonstrating a 0.39% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Ibnsina Pharma's stock price EGP10.34 by its total outstanding shares 9955 (9.96K).
Ibnsina Pharma Market Cap History: 2017 to 2026
Ibnsina Pharma's market capitalization history from 2017 to 2026. Data shows growth from $949.70 to $2.04K (12.15% CAGR).
Ibnsina Pharma Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Ibnsina Pharma's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of ISPH by Market Capitalization
Companies near Ibnsina Pharma in the global market cap rankings as of March 19, 2026.
Key companies related to Ibnsina Pharma by market ranking:
- Data Agro Ltd (KAR:DAAG): Ranked #47372 globally with a market cap of $1.90K USD ( PKRs529.01K PKR).
- Groupimo SA (PA:ALIMO): Ranked #47373 globally with a market cap of $1.90K USD ( €1.85K EUR).
- Elio Motors Inc (PINK:ELIO): Ranked #47382 globally with a market cap of $1.88K USD.
- REGAL PET (BE:RHN): Ranked #47383 globally with a market cap of $1.88K USD ( €1.83K EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #47372 | Data Agro Ltd | KAR:DAAG | $1.90K | PKRs57.19 |
| #47373 | Groupimo SA | PA:ALIMO | $1.90K | €0.20 |
| #47382 | Elio Motors Inc | PINK:ELIO | $1.88K | $0.00 |
| #47383 | REGAL PET | BE:RHN | $1.88K | €0.19 |
Ibnsina Pharma Historical Marketcap From 2017 to 2026
Between 2017 and today, Ibnsina Pharma's market cap moved from $949.70 to $ 2.04K, with a yearly change of 12.15%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | EGP2.04K | -11.77% |
| 2025 | EGP2.31K | +67.43% |
| 2024 | EGP1.38K | +122.93% |
| 2023 | EGP618.25 | +45.37% |
| 2022 | EGP425.29 | -46.93% |
| 2021 | EGP801.36 | -20.04% |
| 2020 | EGP1.00K | -47.90% |
| 2019 | EGP1.92K | -3.74% |
| 2018 | EGP2.00K | +110.43% |
| 2017 | EGP949.70 | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Ibnsina Pharma was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $2.04K USD |
| MoneyControl | $2.04K USD |
| MarketWatch | $2.04K USD |
| marketcap.company | $2.04K USD |
| Reuters | $2.04K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.